Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
20.84
+0.07 (0.34%)
At close: Jan 23, 2026, 4:00 PM EST
20.67
-0.17 (-0.83%)
After-hours: Jan 23, 2026, 5:52 PM EST
Simulations Plus Employees
As of August 31, 2025, Simulations Plus had 213 total employees, including 212 full-time and 1 part-time employees. The number of employees decreased by 34 or -13.77% compared to the previous year.
Employees
213
Change (1Y)
-34
Growth (1Y)
-13.77%
Revenue / Employee
$369,371
Profits / Employee
-$301,634
Market Cap
419.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Aug 31, 2025 | 213 | -34 | -13.77% | 212 | 1 |
| Aug 31, 2024 | 247 | 50 | 25.38% | 243 | 4 |
| Aug 31, 2023 | 197 | 34 | 20.86% | 192 | 5 |
| Aug 31, 2022 | 163 | 17 | 11.64% | 157 | 6 |
| Aug 31, 2021 | 146 | 9 | 6.57% | 135 | 11 |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evolent Health | 4,500 |
| TruBridge | 3,200 |
| Claritev | 2,700 |
| So-Young International | 1,800 |
| HealthStream | 1,093 |
| Weave Communications | 854 |
| Definitive Healthcare | 782 |
| SOPHiA GENETICS | 423 |
SLP News
- 4 days ago - Simulations Plus, Inc. (SLP) Analyst/Investor Day Transcript - Seeking Alpha
- 4 days ago - Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day - Business Wire
- 17 days ago - Simulations Plus, Inc. (SLP) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Simulations Plus Reports First Quarter Fiscal 2026 Financial Results - Business Wire
- 5 weeks ago - Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Business Wire
- 5 weeks ago - Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date - Business Wire
- 6 weeks ago - Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - Business Wire
- 7 weeks ago - Simulations Plus: Buying On Long-Term Silico Drug-Development - Seeking Alpha